DK185283A - Tricycliske forbindelser, deres fremstilling og anvendelse, samt mellemprodukter herfor - Google Patents
Tricycliske forbindelser, deres fremstilling og anvendelse, samt mellemprodukter herfor Download PDFInfo
- Publication number
- DK185283A DK185283A DK185283A DK185283A DK185283A DK 185283 A DK185283 A DK 185283A DK 185283 A DK185283 A DK 185283A DK 185283 A DK185283 A DK 185283A DK 185283 A DK185283 A DK 185283A
- Authority
- DK
- Denmark
- Prior art keywords
- tricyclic
- intermediates
- relationships
- production
- compounds
- Prior art date
Links
- 239000000543 intermediate Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
- C07C65/24—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
- C07D311/82—Xanthenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
- C07D311/82—Xanthenes
- C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
- C07D311/86—Oxygen atoms, e.g. xanthones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8212139 | 1982-04-27 | ||
| GB8212139 | 1982-04-27 | ||
| GB8230055 | 1982-10-21 | ||
| GB8230055 | 1982-10-21 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK185283D0 DK185283D0 (da) | 1983-04-26 |
| DK185283A true DK185283A (da) | 1983-10-28 |
Family
ID=26282657
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK185283A DK185283A (da) | 1982-04-27 | 1983-04-26 | Tricycliske forbindelser, deres fremstilling og anvendelse, samt mellemprodukter herfor |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4902701A (ca) |
| EP (1) | EP0093381B1 (ca) |
| AU (1) | AU566167B2 (ca) |
| CA (1) | CA1222516A (ca) |
| DE (1) | DE3364674D1 (ca) |
| DK (1) | DK185283A (ca) |
| FI (1) | FI82832C (ca) |
| GR (1) | GR78142B (ca) |
| IE (1) | IE55228B1 (ca) |
| IL (1) | IL68498A (ca) |
| NZ (1) | NZ204003A (ca) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8309260D0 (en) * | 1983-04-06 | 1983-05-11 | Erba Farmitalia | Condensed benzopyrone derivatives |
| GB8328494D0 (en) * | 1983-10-25 | 1983-11-23 | Wellcome Found | Liquid containment systems |
| US4861795A (en) * | 1988-06-23 | 1989-08-29 | Rorer Pharmaceutical Corporation | Treatment of conditions requiring enhanced oxygen availability to mammalian tissues |
| US4849416A (en) * | 1988-07-25 | 1989-07-18 | Rorer Pharmaceutical Corporation | Treatment of conditions requiring enhanced oxygen availability to mammalian tissues |
| US4996230A (en) * | 1990-02-16 | 1991-02-26 | Eli Lilly And Company | Leukotriene antagonists |
| IT1261662B (it) * | 1992-09-07 | 1996-05-28 | Inverni Della Beffa Spa | Derivati xantonici, loro preparazione ed attivita' |
| US5624794A (en) * | 1995-06-05 | 1997-04-29 | The Regents Of The University Of California | Method for extending the useful shelf-life of refrigerated red blood cells by flushing with inert gas |
| US5977077A (en) * | 1995-08-28 | 1999-11-02 | Interlab Corporation | Xanthone analogs for the treatment of infectious diseases |
| EP0795554A3 (en) * | 1996-03-05 | 1998-01-28 | Takeda Chemical Industries, Ltd. | (Oxo-)xanthene derivatives, their preparation and their use as immunomodulators |
| US6355153B1 (en) * | 1999-09-17 | 2002-03-12 | Nutool, Inc. | Chip interconnect and packaging deposition methods and structures |
| US7506438B1 (en) * | 2000-11-14 | 2009-03-24 | Freescale Semiconductor, Inc. | Low profile integrated module interconnects and method of fabrication |
| US8828226B2 (en) | 2003-03-01 | 2014-09-09 | The Trustees Of Boston University | System for assessing the efficacy of stored red blood cells using microvascular networks |
| US9199016B2 (en) | 2009-10-12 | 2015-12-01 | New Health Sciences, Inc. | System for extended storage of red blood cells and methods of use |
| US12089589B2 (en) | 2009-10-12 | 2024-09-17 | Hemanext Inc. | Irradiation of red blood cells and anaerobic storage |
| NZ622456A (en) | 2009-10-12 | 2015-09-25 | New Health Sciences Inc | Blood storage bag system and depletion devices with oxygen and carbon dioxide depletion capabilities |
| CA2781874A1 (en) | 2009-10-12 | 2011-04-21 | New Health Sciences, Inc. | Oxygen depletion devices and methods for removing oxygen from red blood cells |
| US11284616B2 (en) | 2010-05-05 | 2022-03-29 | Hemanext Inc. | Irradiation of red blood cells and anaerobic storage |
| EP4091645A1 (en) | 2010-08-25 | 2022-11-23 | Hemanext Inc. | Method for enhancing red blood cell quality and survival during storage |
| WO2012061731A1 (en) | 2010-11-05 | 2012-05-10 | New Health Sciences | Irradiation of red blood cells and anaerobic storage |
| US9067004B2 (en) | 2011-03-28 | 2015-06-30 | New Health Sciences, Inc. | Method and system for removing oxygen and carbon dioxide during red cell blood processing using an inert carrier gas and manifold assembly |
| EP3061509B1 (en) | 2011-08-10 | 2019-05-22 | New Health Sciences, Inc. | Integrated leukocyte, oxygen and/or co2 depletion, and plasma separation filter device |
| CA2902061C (en) | 2013-02-28 | 2023-08-08 | New Health Sciences, Inc. | Gas depletion and gas addition devices for blood treatment |
| IL299978B2 (en) | 2015-03-10 | 2024-08-01 | Hemanext Inc | Single-use oxygen reduction kits, devices and methods for their use |
| EP3285711A4 (en) | 2015-04-23 | 2018-11-07 | New Health Sciences, Inc. | Anaerobic blood storage containers |
| EP4623991A3 (en) | 2015-05-18 | 2025-12-17 | Hemanext Inc. | Methods for the storage of whole blood, and compositions thereof |
| EP3463466B1 (en) | 2016-05-27 | 2022-02-16 | Hemanext Inc. | Anaerobic blood storage and pathogen inactivation method |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2783246A (en) * | 1955-05-02 | 1957-02-26 | Allied Chem & Dye Corp | Manufacture of xanthene |
| BE759292A (fr) * | 1969-11-27 | 1971-05-24 | Allen & Hanburys Ltd | Derives de xanthone, leur preparation et leur emploi |
| US4061768A (en) * | 1971-09-08 | 1977-12-06 | Burroughs Wellcome Co. | Certain cyclic carbonyl compounds used in the prophylaxis of allergic conditions |
| AU478775B2 (en) * | 1974-09-13 | 1974-12-12 | Syntex Gu. S. A. ) Inc | Novel substituted xanthone carboxylic acid compounds |
-
1983
- 1983-04-26 AU AU13924/83A patent/AU566167B2/en not_active Ceased
- 1983-04-26 EP EP83104086A patent/EP0093381B1/en not_active Expired
- 1983-04-26 DE DE8383104086T patent/DE3364674D1/de not_active Expired
- 1983-04-26 CA CA000426692A patent/CA1222516A/en not_active Expired
- 1983-04-26 FI FI831420A patent/FI82832C/fi not_active IP Right Cessation
- 1983-04-26 IE IE949/83A patent/IE55228B1/en unknown
- 1983-04-26 NZ NZ204003A patent/NZ204003A/en unknown
- 1983-04-26 DK DK185283A patent/DK185283A/da not_active Application Discontinuation
- 1983-04-26 IL IL68498A patent/IL68498A/xx unknown
- 1983-04-26 GR GR71216A patent/GR78142B/el unknown
-
1986
- 1986-09-03 US US06/903,834 patent/US4902701A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DK185283D0 (da) | 1983-04-26 |
| FI831420L (fi) | 1983-10-28 |
| GR78142B (ca) | 1984-09-26 |
| IL68498A (en) | 1986-09-30 |
| EP0093381A1 (en) | 1983-11-09 |
| AU1392483A (en) | 1983-11-03 |
| CA1222516A (en) | 1987-06-02 |
| FI82832C (fi) | 1991-04-25 |
| AU566167B2 (en) | 1987-10-08 |
| EP0093381B1 (en) | 1986-07-23 |
| FI831420A0 (fi) | 1983-04-26 |
| DE3364674D1 (en) | 1986-08-28 |
| FI82832B (fi) | 1991-01-15 |
| IE830949L (en) | 1983-10-27 |
| IE55228B1 (en) | 1990-07-04 |
| IL68498A0 (en) | 1983-07-31 |
| NZ204003A (en) | 1986-05-09 |
| US4902701A (en) | 1990-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK185283A (da) | Tricycliske forbindelser, deres fremstilling og anvendelse, samt mellemprodukter herfor | |
| BR9608404A (pt) | Processo para armazenar células sanguìneas vermelhas. | |
| Bodo | The effect of the “heart-tonics” and other drugs upon the heart-tone and coronary circulation | |
| Case et al. | Relative effect of CO2 on canine coronary vascular resistance. | |
| Martin et al. | Acute myocardial infarction in sickle cell anemia | |
| DE58906387D1 (de) | Verwendung von Benzimidazolen zur Herstellung eines Arzneimittels mit antiischämischen Wirkungen am Herzen und dessen Kombinationen mit Beta-Blockern oder Bradycardica. | |
| Sherman et al. | Autologous blood transfusion during cardiopulmonary bypass | |
| Edoute et al. | Evidence for improved myocardial oxygen delivery and function during hypoxia in the mole rat | |
| EP0199117A2 (en) | New therapeutical use of phosphocreatine | |
| Scudder et al. | Studies in blood preservation | |
| Fox et al. | Autologous blood transfusion and intraoperative cell salvage in a patient with homozygous sickle cell disease | |
| Hiatt et al. | Prolongation of survival after circumflex artery ligation by treatment with massive doses of insulin | |
| Selman et al. | The effect of hypothermia on survival rates following coronary occlusion in dogs | |
| JPH11228442A (ja) | 臓器移植後のシクロスポリン投与量を低減するためのフルクトース二リン酸の使用 | |
| Lovric | Alterations in blood components during storage and their clinical significance | |
| RU92013578A (ru) | Способ получения стерильных кожных трансплантатов с бактерицидными свойствами | |
| Nakamura et al. | The shape of embryonic cardiac jelly | |
| Wielhorski et al. | The performance of nine human hearts before, during, and after transplantation | |
| Murfitt et al. | Biochemical characteristics of mitochondrial populations and subpopulations isolated from ischemic canine myocardium | |
| Schwartz et al. | Effect of hypothermia on high-energy phosphate stores and contractile function in supported isolated, blood perfused heart | |
| Jalonen et al. | Reduced Lactate Washout from the Myocardium after Combining St. Thomas I Type Cardioplegia with Topical Cooling of the Heart: Myocardial Oxygenation and Performance after Cardioplegia in Coronary Artery Bypass Grafting Patients | |
| Aono et al. | Oxygen transport and delivery in rabbits treated with cyanate | |
| FA et al. | Myocardial protective effects of warm oxygenated leukocyte-depleted Mood cardioplegia during cardiac valve replacement | |
| LAMSON et al. | STUDIES ON SHOCK INDUCED BY HEMORRHAGE: X. HEMOGLOBIN SOLUTIONS AS BLOOD SUBSTITUTES | |
| THOMAS Jr | The heart in hyperthyroidism |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHS | Application shelved for other reasons than non-payment |